Cash flow Adeka Corporation

Stocks

4401

JP3114800000

Commodity Chemicals

Market Closed - Japan Exchange 10:30:00 14/08/2026 +04			5-day change	1st Jan Change
4,772.00 ^JPY	+1.12%		+1.42%	+23.12%

08-07	Adeka Corporation Revises Dividend Guidance for the Second Quarter End and Full Fiscal Year Ending March 31, 2027	CI
08-07	Adeka Corporation Revises Consolidated Earnings Guidance for the Six Months Ending September 30, 2026 and Full Fiscal Year Ending March 31, 2027	CI

03875cc3585e4efa7767ce.9dXaNOO6muLFCnGF-8kIxWeDLhwfhROqTeIjEmzFgvo.orGPAY_s9IqzRiv2qf9krRTBF1Iy6kfSFa9HTRWgxYnEkahnm8jOq5dyJA

Published financial data: ADEKA CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	363B	403B	400B	407B	417B
Total Revenues	363B	403B	400B	407B	417B
Cost of Goods Sold, Total	267B	305B	295B	292B	298B
Gross Profit	96.52B	98.22B	105B	115B	119B
Selling General & Admin Expenses, Total	53B	56.67B	59.68B	63.42B	64.96B
Provision for Bad Debts	318M	552M	156M	200M	308M
R&D Expenses	8.28B	8.63B	9.43B	10.23B	11.82B
Other Operating Expenses, Total	61.6B	65.85B	69.26B	73.86B	77.09B
Operating Income	34.93B	32.37B	35.43B	41.01B	41.62B
Interest Expense, Total	-855M	-2.47B	-3.72B	-3.44B	-3.59B
Interest And Investment Income	1.24B	2.48B	3.18B	3.25B	3.79B
Net Interest Expenses	387M	9M	-547M	-197M	202M
Income (Loss) On Equity Invest.	463M	512M	537M	619M	715M
Currency Exchange Gains (Loss)	-181M	644M	2B	-3.72B	1.26B
Other Non Operating Income (Expenses)	171M	328M	-338M	231M	1.31B
EBT, Excl. Unusual Items	35.77B	33.86B	37.08B	37.95B	45.11B
Gain (Loss) On Sale Of Investments	72M	1B	529M	1.71B	2.39B
Gain (Loss) On Sale Of Assets	1.87B	51M	56M	1.42B	125M
Asset Writedown	-490M	-5.59B	-1.98B	129M	-3.66B
Legal Settlements	-	-	-	-	-1.07B
Other Unusual Items	-181M	-134M	-2M	-2.3B	-9M
EBT, Incl. Unusual Items	37.04B	29.19B	35.68B	38.91B	42.88B
Income Tax Expense	9.68B	8.23B	9.37B	10.4B	11.16B
Earnings From Continuing Operations	27.36B	20.96B	26.31B	28.52B	31.72B
Net Income to Company	27.36B	20.96B	26.31B	28.52B	31.72B
Minority Interest	-3.62B	-4.18B	-3.33B	-3.5B	-3.85B
Net Income - (IS)	23.74B	16.78B	22.98B	25.02B	27.87B
Net Income to Common Incl Extra Items	23.74B	16.78B	22.98B	25.02B	27.87B
Net Income to Common Excl. Extra Items	23.74B	16.78B	22.98B	25.02B	27.87B
Per Share Items
Net EPS - Basic	230.2	163.3	224.86	245.55	277.95
Basic EPS - Continuing Operations	230.2	163.3	224.86	245.55	277.95
Basic Weighted Average Shares Outstanding	103M	103M	102M	102M	100M
Net EPS - Diluted	230.2	163.3	224.86	245.55	277.95
Diluted EPS - Continuing Operations	230.2	163.3	224.86	245.55	277.95
Diluted Weighted Average Shares Outstanding	103M	103M	102M	102M	100M
Normalized Basic EPS	181.66	165.29	194.19	198.47	242.79
Normalized Diluted EPS	181.66	165.29	194.19	198.47	242.79
Dividend Per Share	70	70	90	100	112
Payout Ratio	22.66	47.37	33.51	40.1	37.88
Supplemental Items
EBITDA	50.55B	48.37B	52.49B	58.57B	60.45B
EBITA	34.93B	32.37B	35.43B	41.01B	41.62B
EBIT	34.93B	32.37B	35.43B	41.01B	41.62B
Effective Tax Rate - (Ratio)	26.13	28.2	26.26	26.72	26.03
Normalized Net Income	18.74B	16.98B	19.84B	20.22B	24.34B
Non-Cash Pension Expense	218M	261M	15M	34M	181M
Supplemental Operating Expense Items
Selling and Marketing Expenses	11.48B	11.34B	10.41B	11.28B	10.7B
Research And Development Expense From Footnotes	14.52B	15.04B	16.13B	17.57B	19.3B

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	84.25B	81.12B	98.43B	110B	96.54B
Short Term Investments	2.5B	5.5B	5.5B	5.49B	8.99B
Total Cash And Short Term Investments	86.75B	86.62B	104B	116B	106B
Accounts Receivable, Total	99.08B	98.45B	116B	109B	115B
Total Receivables	99.08B	98.45B	116B	109B	115B
Inventory	96.08B	117B	115B	113B	120B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	11.96B	13.62B	12.49B	12.23B	14.09B
Total Current Assets	294B	315B	347B	350B	354B
Net Property Plant And Equipment	119B	119B	127B	126B	132B
Long-term Investments	40.16B	41.91B	49.34B	49.35B	55.36B
Goodwill	-	-	-	-	757M
Other Intangibles, Total	16.84B	18.04B	16.5B	14.64B	14.6B
Loans Receivable Long-Term	778M	771M	1.02B	1.11B	677M
Deferred Tax Assets Long-Term	4.34B	4.45B	2.76B	2.26B	2.49B
Other Long-Term Assets, Total	-	2M	3M	2M	2M
Total Assets	475B	500B	543B	543B	560B
Liabilities
Accounts Payable, Total	63.23B	62.24B	64.9B	60.21B	64.35B
Accrued Expenses, Total	3.91B	3.36B	3.71B	3.97B	4.43B
Short-term Borrowings	23.8B	22.3B	26.78B	18.55B	15.6B
Current Portion of Long-Term Debt	1.8B	7.56B	11.88B	7.23B	6.67B
Current Portion of Leases	300M	297M	245M	242M	274M
Current Income Taxes Payable	5.93B	3.25B	4.83B	4.89B	4.64B
Other Current Liabilities	15.88B	30.49B	22.07B	27.15B	19.47B
Total Current Liabilities	115B	129B	134B	122B	115B
Long-Term Debt	29.46B	26.09B	36.66B	37.65B	39.63B
Long-Term Leases	695M	609M	461M	373M	552M
Pension & Other Post Retirement Benefits	21.31B	20.67B	20.6B	19.44B	17.87B
Deferred Tax Liability Non Current	7.05B	6.11B	6.17B	5.43B	8.56B
Other Non Current Liabilities	5.06B	5.39B	5.06B	6.2B	6.38B
Total Liabilities	178B	188B	203B	191B	188B
Common Stock, Total	23.05B	23.05B	23.05B	23.05B	23.05B
Additional Paid In Capital	20.15B	20.13B	20.18B	20.35B	20.46B
Retained Earnings	188B	198B	213B	228B	246B
Treasury Stock	-1.27B	-2.3B	-3.38B	-4.67B	-19B
Comprehensive Income and Other	19.79B	22.24B	32.16B	29.85B	43.38B
Total Common Equity	250B	261B	285B	297B	313B
Minority Interest	46.9B	50.76B	54.54B	55.08B	58.13B
Total Equity	297B	312B	340B	352B	372B
Total Liabilities And Equity	475B	500B	543B	543B	560B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	103M	103M	102M	102M	97.86M
ECS Total Common Shares Outstanding	103M	103M	102M	102M	97.86M
Book Value / Share	2.43K	2.54K	2.79K	2.92K	3.2K
Tangible Book Value	233B	243B	269B	282B	298B
Tangible Book Value Per Share	2.26K	2.37K	2.63K	2.77K	3.05K
Total Debt	56.06B	56.85B	76.04B	64.04B	62.72B
Net Debt	-30.69B	-29.76B	-27.89B	-51.57B	-42.81B
Debt Equivalent of Unfunded Proj. Benefit Obligation	19.51B	17.22B	17.07B	16.92B	15.45B
Minority Interest, Total (Incl. Fin. Div)	46.9B	50.76B	54.54B	55.08B	58.13B
Inventories - Raw Materials, Total	32.6B	40.82B	41.92B	43.43B	41.38B
Inventories - Work In Process, Total	6.24B	8.52B	8.46B	8.43B	8.75B
Inventories - Finished Goods, Total	57.25B	67.37B	64.24B	61.51B	69.41B
Full Time Employees	5.47K	5.49K	5.51K	5.45K	5.43K
Accumulated Allowance for Doubtful Accounts (Supple)	1.38B	1.17B	1.38B	1.38B	1.58B

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	37.04B	29.19B	35.68B	38.91B	42.88B
Depreciation & Amortization - CF	15.62B	16B	17.06B	17.56B	18.84B
Depreciation & Amortization, Total	15.62B	16B	17.06B	17.56B	18.84B
(Gain) Loss From Sale Of Asset	-1.38B	4.25B	609M	-157M	1.2B
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-1.57B	-2.39B
(Income) Loss On Equity Investments - (CF)	-463M	-512M	-537M	-619M	-715M
Other Operating Activities, Total	-8.54B	-12.17B	-6.53B	-10.09B	-12.03B
Change In Accounts Receivable	-5.1B	5.51B	-12.06B	3.95B	-1.86B
Change In Inventories	-22.8B	-17.65B	7.79B	-1.95B	-1.82B
Change In Accounts Payable	9.78B	-4.14B	-934M	-2.82B	-1.41B
Change in Other Net Operating Assets	-2.79B	-3.24B	869M	3.02B	-2.09B
Cash from Operations	21.37B	17.25B	41.95B	46.24B	40.61B
Capital Expenditure	-10.88B	-14.49B	-19.47B	-14.05B	-20.08B
Sale of Property, Plant, and Equipment	2.2B	487M	90M	2.64B	43M
Cash Acquisitions	-10M	-8M	-2.64B	-45M	-24M
Divestitures	-	-	-	1.8B	236M
Sale (Purchase) of Intangible assets	-2.72B	-3.37B	-2.28B	-2.18B	-2.29B
Investment in Marketable and Equity Securities, Total	327M	-1.97B	845M	470M	-8.26B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-14M	-	-302M	-225M	-190M
Other Investing Activities, Total	-223M	-176M	686M	-964M	486M
Cash from Investing	-11.32B	-19.52B	-23.07B	-12.55B	-30.08B
Short Term Debt Issued, Total	428M	-	2.34B	-	-
Long-Term Debt Issued, Total	6.98B	13.74B	23.18B	13.18B	8.19B
Total Debt Issued	7.41B	13.74B	25.51B	13.18B	8.19B
Short Term Debt Repaid, Total	-	-2.62B	-	-7.5B	-3.14B
Long-Term Debt Repaid, Total	-10.62B	-1.86B	-17.71B	-13.89B	-11.67B
Total Debt Repaid	-10.62B	-4.48B	-17.71B	-21.39B	-14.81B
Repurchase of Common Stock	-	-	-	-	-14.5B
Common Dividends Paid	-5.38B	-7.95B	-7.7B	-10.03B	-10.56B
Common & Preferred Stock Dividends Paid	-5.38B	-7.95B	-7.7B	-10.03B	-10.56B
Other Financing Activities, Total	-3.26B	-3.93B	-4.66B	-4.04B	-3.63B
Cash from Financing	-11.85B	-2.62B	-4.56B	-22.29B	-35.3B
Foreign Exchange Rate Adjustments	2.48B	1.62B	2.99B	-1.38B	3.99B
Miscellaneous Cash Flow Adjustments	-1M	-	44M	856M	890M
Net Change in Cash	677M	-3.26B	17.36B	10.87B	-19.88B
Supplemental Items
Cash Interest Paid	814M	2.08B	3.24B	4.22B	3.63B
Cash Income Tax Paid (Refund)	8.82B	12.64B	7.52B	9.8B	12.05B
Levered Free Cash Flow	270M	5.56B	-2.58B	33.91B	2.35B
Unlevered Free Cash Flow	804M	7.1B	-250M	36.06B	4.59B
Change In Net Working Capital	23.05B	11.28B	17.71B	-9.1B	17.88B
Net Debt Issued / Repaid	-3.21B	9.26B	7.8B	-8.21B	-6.62B

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	4.78	4.15	4.25	4.72	4.72
Return on Total Capital	6.4	5.61	5.65	6.16	6.12
Return On Equity %	9.63	6.89	8.08	8.25	8.77
Return on Common Equity	9.93	6.57	8.42	8.6	9.13
Margin Analysis
Gross Profit Margin %	26.59	24.35	26.19	28.21	28.5
SG&A Margin	14.6	14.05	14.93	15.58	15.59
EBITDA Margin %	13.92	11.99	13.13	14.38	14.51
EBITA Margin %	9.62	8.03	8.86	10.07	9.99
EBIT Margin %	9.62	8.03	8.86	10.07	9.99
Income From Continuing Operations Margin %	7.54	5.2	6.58	7	7.61
Net Income Margin %	6.54	4.16	5.75	6.14	6.69
Net Avail. For Common Margin %	6.54	4.16	5.75	6.14	6.69
Normalized Net Income Margin	5.16	4.21	4.96	4.97	5.84
Levered Free Cash Flow Margin	0.07	1.38	-0.64	8.33	0.56
Unlevered Free Cash Flow Margin	0.22	1.76	-0.06	8.86	1.1
Asset Turnover
Asset Turnover	0.8	0.83	0.77	0.75	0.76
Fixed Assets Turnover	3.05	3.38	3.25	3.22	3.23
Receivables Turnover (Average Receivables)	3.83	4.08	3.74	3.63	3.72
Inventory Turnover (Average Inventory)	3.21	2.87	2.55	2.56	2.56
Short Term Liquidity
Current Ratio	2.56	2.44	2.58	2.86	3.07
Quick Ratio	1.62	1.43	1.63	1.83	1.91
Operating Cash Flow to Current Liabilities	0.19	0.13	0.31	0.38	0.35
Days Sales Outstanding (Average Receivables)	95.3	89.37	97.96	100.51	98.08
Days Outstanding Inventory (Average Inventory)	113.58	127.28	143.47	142.35	142.7
Average Days Payable Outstanding	70.73	70.29	79.41	78.46	74.77
Cash Conversion Cycle (Average Days)	138.15	146.36	162.02	164.41	166.02
Long Term Solvency
Total Debt/Equity	18.88	18.24	22.38	18.2	16.88
Total Debt / Total Capital	15.88	15.43	18.29	15.4	14.44
LT Debt/Equity	10.16	8.57	10.93	10.81	10.81
Long-Term Debt / Total Capital	8.54	7.24	8.93	9.14	9.25
Total Liabilities / Total Assets	37.54	37.67	37.45	35.23	33.65
EBIT / Interest Expense	40.85	13.11	9.52	11.9	11.6
EBITDA / Interest Expense	59.12	19.58	14.1	17	16.85
(EBITDA - Capex) / Interest Expense	46.4	13.72	8.87	12.92	11.25
Total Debt / EBITDA	1.11	1.18	1.45	1.09	1.04
Net Debt / EBITDA	-0.61	-0.62	-0.53	-0.88	-0.71
Total Debt / (EBITDA - Capex)	1.41	1.68	2.3	1.44	1.55
Net Debt / (EBITDA - Capex)	-0.77	-0.88	-0.84	-1.16	-1.06
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	10.99	11.1	-0.89	1.84	2.31
Gross Profit, 1 Yr. Growth %	11.29	1.76	6.59	9.72	3.34
EBITDA, 1 Yr. Growth %	14.75	-4.3	8.52	11.57	3.22
EBITA, 1 Yr. Growth %	20.52	-7.32	9.45	15.76	1.47
EBIT, 1 Yr. Growth %	20.52	-7.32	9.45	15.76	1.47
Earnings From Cont. Operations, 1 Yr. Growth %	40.75	-23.4	25.52	8.38	11.23
Net Income, 1 Yr. Growth %	44.61	-29.34	36.95	8.89	11.38
Normalized Net Income, 1 Yr. Growth %	24.17	-9.36	16.84	1.91	20.37
Diluted EPS Before Extra, 1 Yr. Growth %	44.77	-29.06	37.7	9.2	13.19
Accounts Receivable, 1 Yr. Growth %	9.47	-0.63	17.38	-5.95	5.99
Inventory, 1 Yr. Growth %	37.69	21.47	-1.79	-1.09	5.45
Net Property, Plant and Equip., 1 Yr. Growth %	0.34	0.14	6.15	-0.77	4.67
Total Assets, 1 Yr. Growth %	8.6	5.21	8.6	0.01	3.11
Tangible Book Value, 1 Yr. Growth %	10.01	4.2	10.6	4.99	5.69
Common Equity, 1 Yr. Growth %	9.6	4.39	9.27	4.05	5.64
Cash From Operations, 1 Yr. Growth %	-42.05	-19.25	143.17	10.2	-12.16
Capital Expenditures, 1 Yr. Growth %	-15.84	33.16	34.39	-27.86	42.97
Levered Free Cash Flow, 1 Yr. Growth %	-98.29	1.96K	-146.34	-1.42K	-93.07
Unlevered Free Cash Flow, 1 Yr. Growth %	-95.08	783.57	-103.52	-14.53K	-87.27
Dividend Per Share, 1 Yr. Growth %	45.83	0	28.57	11.11	12
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	9.26	11.05	4.94	0.47	2.08
Gross Profit, 2 Yr. CAGR %	10.15	6.42	4.15	8.14	6.48
EBITDA, 2 Yr. CAGR %	17.25	4.79	1.91	10.03	7.31
EBITA, 2 Yr. CAGR %	24.54	5.69	0.71	12.56	8.38
EBIT, 2 Yr. CAGR %	24.54	5.69	0.71	12.56	8.38
Earnings From Cont. Operations, 2 Yr. CAGR %	25.76	3.84	-1.94	16.64	9.79
Net Income, 2 Yr. CAGR %	24.92	1.09	-1.63	22.11	10.13
Normalized Net Income, 2 Yr. CAGR %	26.82	6.09	2.91	9.12	10.76
Diluted EPS Before Extra, 2 Yr. CAGR %	24.85	1.34	-1.17	22.62	11.18
Accounts Receivable, 2 Yr. CAGR %	8.39	4.3	8	5.07	-0.16
Inventory, 2 Yr. CAGR %	17.96	29.33	9.22	-1.44	2.13
Net Property, Plant and Equip., 2 Yr. CAGR %	2.65	0.24	3.1	2.63	1.92
Total Assets, 2 Yr. CAGR %	7.74	6.89	6.89	4.22	1.55
Tangible Book Value, 2 Yr. CAGR %	9.65	7.06	7.35	7.76	5.34
Common Equity, 2 Yr. CAGR %	9.03	6.96	6.8	6.63	4.84
Cash From Operations, 2 Yr. CAGR %	-11.69	-31.6	40.12	63.7	-1.61
Capital Expenditures, 2 Yr. CAGR %	-19.54	5.86	33.78	-1.54	1.56
Levered Free Cash Flow, 2 Yr. CAGR %	-71.55	-40.57	209.14	146.95	-4.5
Unlevered Free Cash Flow, 2 Yr. CAGR %	-55.32	-34.05	-44.25	125.31	328.7
Dividend Per Share, 2 Yr. CAGR %	20.76	20.76	13.39	19.52	11.55
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.64	9.87	6.92	3.9	1.08
Gross Profit, 3 Yr. CAGR %	9	7.28	6.47	5.97	6.52
EBITDA, 3 Yr. CAGR %	9.69	9.58	6.02	5.03	7.71
EBITA, 3 Yr. CAGR %	9.45	12.86	6.93	5.5	8.73
EBIT, 3 Yr. CAGR %	9.45	12.86	6.93	5.5	8.73
Earnings From Cont. Operations, 3 Yr. CAGR %	12.15	6.61	10.61	1.39	14.81
Net Income, 3 Yr. CAGR %	11.66	3.31	11.85	1.76	18.43
Normalized Net Income, 3 Yr. CAGR %	9.47	13.39	9.56	2.58	12.75
Diluted EPS Before Extra, 3 Yr. CAGR %	11.57	3.41	12.24	2.17	19.4
Accounts Receivable, 3 Yr. CAGR %	2.14	5.29	8.49	3.13	5.38
Inventory, 3 Yr. CAGR %	11.08	19.12	17.99	5.67	0.8
Net Property, Plant and Equip., 3 Yr. CAGR %	3.16	1.81	2.18	1.8	3.31
Total Assets, 3 Yr. CAGR %	4.66	6.89	7.46	4.55	3.84
Tangible Book Value, 3 Yr. CAGR %	7.63	7.8	8.23	6.56	7.06
Common Equity, 3 Yr. CAGR %	6.91	7.46	7.73	5.88	6.3
Cash From Operations, 3 Yr. CAGR %	5.24	-14.29	4.4	29.34	33.02
Capital Expenditures, 3 Yr. CAGR %	-12.83	-4.83	14.63	8.89	11.5
Levered Free Cash Flow, 3 Yr. CAGR %	-78.23	18.63	-45.3	401.01	-24.96
Unlevered Free Cash Flow, 3 Yr. CAGR %	-68.49	20.82	-75.18	255.3	-13.53
Dividend Per Share, 3 Yr. CAGR %	15.87	13.4	23.31	12.62	16.96
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.19	10.98	5.96	6.01	4.96
Gross Profit, 5 Yr. CAGR %	11.56	11.2	7.03	7.62	6.48
EBITDA, 5 Yr. CAGR %	10.8	9.31	6.51	9.76	6.53
EBITA, 5 Yr. CAGR %	10.67	8.69	5.87	12.74	7.51
EBIT, 5 Yr. CAGR %	10.67	8.69	5.87	12.74	7.51
Earnings From Cont. Operations, 5 Yr. CAGR %	11	5.23	6.29	10.51	10.28
Net Income, 5 Yr. CAGR %	9.15	1.8	6.14	10.46	11.16
Normalized Net Income, 5 Yr. CAGR %	8.02	5.39	6.8	11.66	10.03
Diluted EPS Before Extra, 5 Yr. CAGR %	9.09	1.83	6.29	10.7	11.82
Accounts Receivable, 5 Yr. CAGR %	14.67	12.33	4.45	5.2	4.94
Inventory, 5 Yr. CAGR %	18.45	20.36	10.33	10.42	11.37
Net Property, Plant and Equip., 5 Yr. CAGR %	8.29	6.91	3.14	2.14	2.07
Total Assets, 5 Yr. CAGR %	10.35	9.83	5.55	5.81	5.05
Tangible Book Value, 5 Yr. CAGR %	5.77	4.76	7.52	7.78	7.06
Common Equity, 5 Yr. CAGR %	6.78	5.82	6.87	7.13	6.57
Cash From Operations, 5 Yr. CAGR %	-0.75	-4.94	18.01	11.03	1.95
Capital Expenditures, 5 Yr. CAGR %	0.49	1.25	3.46	-3.52	9.21
Levered Free Cash Flow, 5 Yr. CAGR %	-44.23	-6.1	-37.07	59.06	-31.64
Unlevered Free Cash Flow, 5 Yr. CAGR %	-31.25	-1.98	-60.41	55.02	-22.41
Dividend Per Share, 5 Yr. CAGR %	18.47	12.41	14.87	15.81	18.47